A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection

por Iwata-Yoshikawa, Naoko, Shiwa, Nozomi, Sekizuka, Tsuyoshi, Sano, Kaori, Ainai, Akira, Hemmi, Takuya, Kataoka, Michiyo, Kuroda, Makoto, Hasegawa, Hideki, Suzuki, Tadaki, Nagata, Noriyo
Publicado 2022

Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses

por Kotani, Osamu, Suzuki, Yasushi, Saito, Shinji, Ainai, Akira, Ueno, Akira, Hemmi, Takuya, Sano, Kaori, Tabata, Koshiro, Yokoyama, Masaru, Suzuki, Tadaki, Hasegawa, Hideki, Sato, Hironori
Publicado 2021

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults

por Sonoyama, Takuhiro, Iwata, Satoshi, Shinkai, Masaharu, Iwata-Yoshikawa, Naoko, Shiwa-Sudo, Nozomi, Hemmi, Takuya, Ainai, Akira, Nagata, Noriyo, Matsunaga, Nobuaki, Tada, Yukio, Homma, Tomoyuki, Omoto, Shinya, Yokokawa Shibata, Risa, Igarashi, Kenji, Suzuki, Tadaki, Hasegawa, Hideki, Ariyasu, Mari
Publicado 2023

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

por Hemmi, Takuya, Ainai, Akira, Hashiguchi, Takao, Tobiume, Minoru, Kanno, Takayuki, Iwata-Yoshikawa, Naoko, Iida, Shun, Sato, Yuko, Miyamoto, Sho, Ueno, Akira, Sano, Kaori, Saito, Shinji, Shiwa-Sudo, Nozomi, Nagata, Noriyo, Tamura, Koji, Suzuki, Ryosuke, Hasegawa, Hideki, Suzuki, Tadaki
Publicado 2022

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization

por Miyamoto, Sho, Arashiro, Takeshi, Ueno, Akira, Kanno, Takayuki, Saito, Shinji, Katano, Harutaka, Iida, Shun, Ainai, Akira, Ozono, Seiya, Hemmi, Takuya, Hirata, Yuichiro, Moriyama, Saya, Kotaki, Ryutaro, Kinoshita, Hitomi, Yamada, Souichi, Shinkai, Masaharu, Fukushi, Shuetsu, Takahashi, Yoshimasa, Suzuki, Tadaki
Publicado 2023

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

por Miyamoto, Sho, Arashiro, Takeshi, Adachi, Yu, Moriyama, Saya, Kinoshita, Hitomi, Kanno, Takayuki, Saito, Shinji, Katano, Harutaka, Iida, Shun, Ainai, Akira, Kotaki, Ryutaro, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Ishijima, Keita, Park, Eun-Sil, Inoue, Yusuke, Kaku, Yoshihiro, Tobiume, Minoru, Iwata-Yoshikawa, Naoko, Shiwa-Sudo, Nozomi, Tokunaga, Kenzo, Ozono, Seiya, Hemmi, Takuya, Ueno, Akira, Kishida, Noriko, Watanabe, Shinji, Nojima, Kiyoko, Seki, Yohei, Mizukami, Takuo, Hasegawa, Hideki, Ebihara, Hideki, Maeda, Ken, Fukushi, Shuetsu, Takahashi, Yoshimasa, Suzuki, Tadaki
Publicado 2022